1. Home
  2. LPTH vs REPL Comparison

LPTH vs REPL Comparison

Compare LPTH & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LightPath Technologies Inc.

LPTH

LightPath Technologies Inc.

HOLD

Current Price

$13.59

Market Cap

745.9M

Sector

Technology

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$7.24

Market Cap

781.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LPTH
REPL
Founded
1985
2015
Country
United States
United States
Employees
350
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
745.9M
781.3M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
LPTH
REPL
Price
$13.59
$7.24
Analyst Decision
Strong Buy
Buy
Analyst Count
3
9
Target Price
$11.67
$12.00
AVG Volume (30 Days)
2.9M
1.4M
Earning Date
02-12-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,860,530.00
N/A
Revenue This Year
$68.82
N/A
Revenue Next Year
$23.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
36.85
N/A
52 Week Low
$1.61
$2.68
52 Week High
$15.04
$14.80

Technical Indicators

Market Signals
Indicator
LPTH
REPL
Relative Strength Index (RSI) 68.64 28.73
Support Level $11.81 $6.77
Resistance Level $15.04 $9.41
Average True Range (ATR) 1.38 0.55
MACD 0.14 -0.19
Stochastic Oscillator 65.19 11.96

Price Performance

Historical Comparison
LPTH
REPL

About LPTH LightPath Technologies Inc.

LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: